Ralph Arlinghaus Selected Research

Ralph Arlinghaus Research Topics

9	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2013 - 06/2002
4	Neoplasms (Cancer) 10/2012 - 05/2002
3	Leukemia 04/2008 - 05/2005
2	Breast Neoplasms (Breast Cancer) 10/2012 - 05/2002
2	Philadelphia Chromosome 01/2003 - 01/2003
1	Colorectal Neoplasms (Colorectal Cancer) 10/2012
1	Carcinoma (Carcinomatosis) 05/2009
1	Body Weight (Weight, Body) 11/2007
1	Disease Progression 01/2003
1	Residual Neoplasm 01/2003
1	Agranulocytosis (Granulocytopenia) 09/2002
1	Thrombocytopenia (Thrombopenia) 09/2002

8	Imatinib Mesylate (Gleevec)FDA Link 03/2013 - 06/2002
3	Lipocalin-2IBA 05/2009 - 04/2008
2	Oncogene Proteins (Oncogene Protein)IBA 01/2011 - 04/2008
2	Proteins (Proteins, Gene)FDA Link 11/2007 - 01/2004
1	Indicators and Reagents (Reagents)IBA 10/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2012
1	CateninsIBA 05/2009
1	IronIBA 05/2009
1	Cadherins (E-Cadherin)IBA 05/2009
1	Monomeric GTP-Binding ProteinsIBA 05/2009
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2009
1	Iron-Regulatory Proteins (Iron-Responsive Element Binding Proteins)IBA 05/2009
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2008
1	Liposomes (Liposome)IBA 11/2007
1	Messenger RNA (mRNA)IBA 11/2007
1	OligonucleotidesIBA 11/2007
1	OligodeoxyribonucleotidesIBA 11/2007
1	Small Interfering RNA (siRNA)IBA 05/2005
1	Phosphotransferases (Kinase)IBA 01/2003
1	Tyrosine Kinase InhibitorsIBA 01/2003
1	Tyrosine (L-Tyrosine)FDA Link 05/2002